1593.1 – Bioinductive implant for the repair of rotator cuff tear

Page last updated: 27 February 2024

Application Detail

Description of Medical Service

Insertion of a bioinductive collagen implant (REGENETEN), to induce formation of new tendon-like tissue that biologically augments the degenerated rotator cuff tendon. The physical and chemical properties of the scaffold provide a layer of collagen between a flat tendon and surrounding tissue, permitting collagen in-growth into the scaffold, and promoting collagen re-modelling with alignment of the collagen fibres in the direction of the stress in the tendon. The scaffold is hydrated in saline and positioned arthroscopically through a small incision over the tendon, with one end overlapping the tendon insertion.

Description of Medical Condition

A rotator cuff tear is the partial or full detachment of the tendon that attaches the muscles from the shoulder blade to the head of the humerus. The cause of the tear is multifactorial and likely a combination of age-related chronic degeneration of the tendon, direct micro/macro trauma, impingement and/or repetitive or vigorous overhead activity of the arm

Reason for Application

Referral from Prostheses List Advisory Committee

Medical Service Type

Therapeutic technology

Previous Application Number/s


Associated Documentation

Application Summary and PICO Set

Application Summary (PDF 398 KB)
Application Summary (Word 24 KB)

PICO Set (PDF 1361 KB)
PICO Set (Word 230 KB)

Consultation Survey

Consultation Survey (PDF 653 KB)
Consultation Survey (Word 27 KB)

PASC Consultation
PASC consultation closed

MSAC Consultation
MSAC consultation input must be received by no later than Friday, 14 June 2024 for it to be considered by MSAC at its August 2024 meeting.

For further information please refer to PASC, ESC, MSAC Key Dates

For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

PICO Confirmation (PDF 2188 KB)
PICO Confirmation (Word 660 KB)

Assessment Report


Public Summary Document


Meetings for this Application


10-11 August 2023


13-14 June 2024


1-2 August 2024